BIOTECHNOLOGY: The Patenting of DNA

摘要: John J. Doll There has been considerable controversy in the biotechnology community regarding patenting of DNA sequence. In this Policy Forum, U.S. Patent and Trademark Office presents its view that, as other fields technology, DNA-related inventions may be patentable if they meet all conditions for patentability, including, example, utility, novelty, nonobviousness, written description enablement. Issuing a patent on fragment gene does not preclude future full-length but to dominate later gene. The granting comprehensive claims downstream products such genes or ultimate proteins is unlikely absence significant amount information about protein being disclosed application.